QUETIAPINE RC B 90 % Above
Price | Get Latest Price | |||
Packge | 25mg | 100mg | 250mg | 50010500 mg and 1.0 gm |
- Min. Order:25mg
- Time:2024-04-30
Product Details
- Product NameQUETIAPINE RC B
- CAS No.111974-74-4
- EINECS No.1312995-182-4
- MFC17H18ClN3S
- MW331.86
- AppearancesolidOff-white
- Melting point 180-184°C
- storage temp. Inert atmosphere,2-8°C
Company Profile Introduction
Clickchem research LLP started in 2021, we are leading manufacturing and supplier of pharmaceutical materials like API Intermediates, impurities and catalyst, We provide services regarding purification, isolation, & characterisation of unknown molecules and develop the R&D route to synthesis the target molecules to our customers on contract basis for critical molecules.
Supplier other products
Recommended supplier
-
VIP1年
- Allmpus Laboratories Pvt Ltd
- Quetiapine EP Impurity B | Quetiapine USP Related Compound B 111974-74-4 97.32
- Inquiry
- 2024-09-14
-
VIP1年
- Satya Sree Labs
- 11-Piperazinodibenzo[b,f][1,4]thiazepine dihydrochloride 98%
- Inquiry
- 2024-02-24
-
VIP1年
- Ralington Pharma
- 111974-74-4 98%
- Inquiry
- 2024-02-05
-
VIP1年
- Saburi Life Sciences
- 111974-74-4 11-Piperazinodibenzo[b,f][1,4]thiazepine dihydrochloride 98%
- Inquiry
- 2024-01-27
-
VIP1年
- Aventus Labs
- 11-Piperazinodibenzo[b,f][1,4]thiazepine dihydrochloride 111974-74-4 98%
- Inquiry
- 2024-01-19
-
VIP1年
- Aruvi Labs
- 11-Piperazinodibenzo[b,f][1,4]thiazepine dihydrochloride 98%
- Inquiry
- 2024-01-16
-
VIP1年
- Vasoya Industries Pvt Ltd
- 111974-74-4 99%
- Inquiry
- 2024-01-11
-
VIP1年
- Lakshmi Farmachem
- 11-Piperazinodibenzo[b,f][1,4]thiazepine dihydrochloride 98%
- Inquiry
- 2024-01-11
-
VIP1年
- Aarti Industries Limited (AIL)
- 11-Piperazinodibenzo[b,f][1,4]thiazepine dihydrochloride 111974-74-4 98%
- Inquiry
- 2024-01-08
-
VIP1年
- R L Fine Chem Pvt. Ltd
- 11-Piperazinodibenzo[b,f][1,4]thiazepine dihydrochloride 98%
- Inquiry
- 2024-01-05
- Since:2020-04-01
- Address: Plot- 2900/36 Near Atul Ltd, Opp Cadila Pharma Unit-1, G.I.D.C, Ankleshwar GUJARAT
INQUIRY